Aggravation of experimental autoimmune neuritis in TNF-α receptor 1 deficient mice

Journal of Neuroimmunology

Volumn 186, Issue 1-2, 2007, Pages 19-26

  Lu, Ming Ou ^a   Duan, Rui Sheng ^a   Quezada, Hernan Concha ^b   Chen, Zhi Guo ^a   Mix, Eilhard ^c   Jin, Tao ^a,d   Yang, Xin ^a,d   Ljunggren, Hans Gustaf ^b   Zhu, Jie ^a,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d JILIN UNIVERSITY   (China)

Author keywords

Cytokine; EAN; Knockout mice; TNF ; TNF receptor I

Indexed keywords

CHEMOKINE RECEPTOR CCR3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CAUDA EQUINA; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MOUSE; NEURITIS; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; WILD TYPE;

ANIMALS; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN P0 PROTEIN; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RECEPTORS, CHEMOKINE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SCHWANN CELLS; SEVERITY OF ILLNESS INDEX; THYMIDINE;

EID: 34248671665     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.02.004     Document Type: Article

References (29)

1. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., and Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4 11 (2001) 1116-1122
2. Bao L., Lindgren J.U., Meide P., van der, Zhu S.W., Ljunggren H.G., and Zhu J. IL-12 is decisive for initiating, enhancing and perpetuating pathogenic events in murine experimental autoimmune neuritis. Brain Pathol. 12 4 (2002) 420-429
3. Bao L., Lindgren J.U., Zhu Y., Ljunggren H.G., and Zhu J. Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis. Neurobiol. Dis. 12 1 (2003) 73-81
4. Cope A., Ettinger R., and McDevitt H. The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire. Res. Immunol. 148 5 (1997) 307-312
5. Duan R.S., Chen Z., Bao L., Quezada H.C., Nennesmo I., Winblad B., and Zhu J. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis. Neurobiol. Dis. 16 3 (2004) 630-637
6. Eugster H.P., Frei K., Bachmann R., Bluethmann H., Lassmann H., and Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 29 2 (1999) 626-632
7. Exley A.R., Smith N., and Winer J.B. Tumour necrosis factor-alpha and other cytokines in Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry 57 9 (1994) 1118-1120
8. Frei K., Eugster H.P., Bopst M., Constantinescu C.S., Lavi E., and Fontana A. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185 12 (1997) 2177-2182
9. Gold R., Hartung H.P., and Toyka K.V. Animal models for autoimmune demyelinating disorders of the nervous system. Mol. Med. Today 6 2 (2000) 88-91
10. Huang C.J., Nazarian R., Lee J., Zhao P.M., Espinosa-Jeffrey A., and de Vellis J. Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line. Int. J. Dev. Neurosci. 20 3-5 (2002) 289-296
11. Jasinski M., Wieckiewicz J., Ruggiero I., Pituch-Noworolska A., and Zembala M. Isotype-specific regulation of MHC class II gene expression in human monocytes by exogenous and endogenous tumor necrosis factor. J. Clin. Immunol. 15 4 (1995) 185-193
12. Kassiotis G., and Kollias G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 193 4 (2001) 427-434
13. Korner H., Riminton D.S., Strickland D.H., Lemckert F.A., Pollard J.D., and Sedgwick J.D. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 186 9 (1997) 1585-1590
14. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., and Bernard C.C. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4 1 (1998) 78-83
15. Maeda Y., Maeda R., Prineas J.W., and Ledeen R.W. Phosphatidylserine suppresses myelin-induced experimental allergic neuritis (EAN) in Lewis rats. J. Neuropathol. Exp. Neurol. 53 6 (1994) 672-677
16. McDevitt H., Munson S., Ettinger R., and Wu A. Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity. Arthritis Res. 4 Suppl 3 (2002) S141-S152
17. McFarland H.I., Critchfield J.M., Racke M.K., Mueller J.P., Nye S.H., Boehme S.A., and Lenardo M.J. Amelioration of autoimmune reactions by antigen-induced apoptosis of T cells. Adv. Exp. Med. Biol. 383 (1995) 157-166
18. Olleros M.L., Guler R., Corazza N., Vesin D., Eugster H.P., Marchal G., Chavarot P., et al. Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-alpha. J. Immunol. 168 7 (2002) 3394-3401
19. Vassalli P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10 (1992) 411-452
20. Ware C.F., Crowe P.D., Vanarsdale T.L., Andrews J.L., Grayson M.H., Jerzy R., Smith C.A., and Goodwin R.G. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J. Immunol. 147 12 (1991) 4229-4238
21. Weishaupt A., Gold R., Hartung T., Gaupp S., Wendel A., Bruck W., and Toyka K.V. Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis. J. Neuropathol. Exp. Neurol. 59 5 (2000) 368-376
22. Yang Y.C., Hsu T.Y., Chen J.Y., Yang C.S., and Lin R.H. Tumour necrosis factor-alpha-induced apoptosis in cord blood T lymphocytes: involvement of both tumour necrosis factor receptor types 1 and 2. Br. J. Haematol. 115 2 (2001) 435-441
23. Zheng L., Fisher G., Miller R.E., Peschon J., Lynch D.H., and Lenardo M.J. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377 6547 (1995) 348-351
24. Zhu J., Bai X.F., Mix E., and Link H. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clin. Immunol. Immunopathol. 84 1 (1997) 85-94
25. Zhu J., Bai X.F., Mix E., and Link H. Experimental allergic neuritis: cytolysin mRNA expression is upregulated in lymph node cells during convalescence. J. Neuroimmunol. 78 1-2 (1997) 108-116
26. Zhu J., Mix E., and Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome. J. Neuroimmunol. 84 1 (1998) 40-52
27. Zhu W., Mix E., and Zhu J. Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats. J. Neuroimmunol. 140 1-2 (2003) 97-101
28. Zhu W., Mix E., Nennesmo I., Adem A., and Zhu J. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats. Exp. Neurol. 190 2 (2004) 486-494
29. Zou L.P., Deretzi G., Pelidou S.H., Levi M., Wahren B., Quiding C., van der Meide P., and Zhu J. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats. Neuropharmacology 39 2 (2000) 324-333